Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 70270

1.

Gene Therapy Corrects Mitochondrial Dysfunction in Hematopoietic Progenitor Cells and Fibroblasts from Coq9R239X Mice.

Barriocanal-Casado E, Cueto-Ureña C, Benabdellah K, Gutiérrez-Guerrero A, Cobo M, Hidalgo-Gutiérrez A, Rodríguez-Sevilla JJ, Martín F, López LC.

PLoS One. 2016 Jun 24;11(6):e0158344. doi: 10.1371/journal.pone.0158344. eCollection 2016.

PMID:
27341668
2.

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.

Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F.

PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.

PMID:
27341514
3.

Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p.

Fooladinezhad H, Khanahmad H, Ganjalikhani-Hakemi M, Doosti A.

Br J Biomed Sci. 2016 Jun 24:1-5. [Epub ahead of print]

PMID:
27341144
4.
5.

A mechanism for 1,4-Benzoquinone-induced genotoxicity.

Young Son M, Deng CX, Hoeijmarkers JH, Rebel VI, Hasty P.

Oncotarget. 2016 Jun 20. doi: 10.18632/oncotarget.10184. [Epub ahead of print]

PMID:
27340773
6.

Agent-Based Deterministic Modeling of the Bone Marrow Homeostasis.

Kurhekar M, Deshpande U.

Adv Bioinformatics. 2016;2016:8054219. doi: 10.1155/2016/8054219. Epub 2016 Jun 2.

PMID:
27340402
7.

Formaldehyde induces toxicity in mouse bone marrow and hematopoietic stem/progenitor cells and enhances benzene-induced adverse effects.

Wei C, Wen H, Yuan L, McHale CM, Li H, Wang K, Yuan J, Yang X, Zhang L.

Arch Toxicol. 2016 Jun 23. [Epub ahead of print]

PMID:
27339418
8.

A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis.

Ebert LM, Tan LY, Johan MZ, Min KK, Cockshell MP, Parham KA, Betterman KL, Szeto P, Boyle S, Silva L, Peng A, Zhang Y, Ruszkiewicz A, Zannettino AC, Gronthos S, Koblar S, Harvey NL, Lopez AF, Shackleton M, Bonder CS.

Angiogenesis. 2016 Jun 23. [Epub ahead of print]

PMID:
27338829
9.

NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation.

Boztug H, Hirschmugl T, Holter W, Lakatos K, Kager L, Trapin D, Pickl W, Förster-Waldl E, Boztug K.

J Clin Immunol. 2016 Jun 23. [Epub ahead of print]

PMID:
27338827
10.

p38 MAPK Inhibitor Insufficiently Attenuates HSC Senescence Administered Long-Term after 6 Gy Total Body Irradiation in Mice.

Lu L, Wang YY, Zhang JL, Li DG, Meng AM.

Int J Mol Sci. 2016 Jun 8;17(6). pii: E905. doi: 10.3390/ijms17060905.

PMID:
27338355
11.

Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines.

Mohanty S, Mohanty A, Sandoval N, Tran T, Bedell V, Wu J, Scuto A, Murata-Collins J, Weisenburger DD, Ngo VN.

Leuk Lymphoma. 2016 Jun 24:1-13. [Epub ahead of print]

PMID:
27338091
12.

Multiple roles of CD90 in cancer.

Kumar A, Bhanja A, Bhattacharyya J, Jaganathan BG.

Tumour Biol. 2016 Jun 23. [Epub ahead of print] Review.

PMID:
27337957
13.

Gram-scale Laboratory Synthesis of UM171, a Potent Agonist of Human Hematopoietic Stem Cell Self-renewal.

Ali S, Yu SM, Yao ZJ.

J Org Chem. 2016 Jun 23. [Epub ahead of print]

PMID:
27337543
14.

Pharmacological preconditioning for short-term ex vivo expansion of human umbilical cord blood hematopoietic stem cells by filgrastim.

Grigoriadis NG, Grigoriadis IG, Markoula S, Paschopoulos M, Zikopoulos K, Apostolakopoulos PG, Vizirianakis IS, Georgiou I.

Am J Stem Cells. 2016 May 15;5(1):29-38. eCollection 2016.

PMID:
27335700
15.

Case of relentless chronic phase of chronic myeloid leukaemia.

Chan O, Chen H, Krishnadasan R, Anwer F.

BMJ Case Rep. 2016 Jun 22;2016. pii: bcr2016215370. doi: 10.1136/bcr-2016-215370.

PMID:
27335363
16.

Systematic tracking of altered haematopoiesis during sporozoite-mediated malaria development reveals multiple response points.

Vainieri ML, Blagborough AM, MacLean AL, Haltalli ML, Ruivo N, Fletcher HA, Stumpf MP, Sinden RE, Celso CL.

Open Biol. 2016 Jun;6(6). pii: 160038. doi: 10.1098/rsob.160038.

17.

DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.

Rau RE, Rodriguez B, Luo M, Jeong M, Rosen A, Rogers JH, Campbell CT, Daigle SR, Deng L, Song Y, Sweet S, Chevassut T, Andreeff M, Kornblau SM, Li W, Goodell MA.

Blood. 2016 Jun 22. pii: blood-2015-11-684225. [Epub ahead of print]

PMID:
27335278
18.

Generation of a Bone Organ by Human Adipose-Derived Stromal Cells Through Endochondral Ossification.

Osinga R, Di Maggio N, Todorov A, Allafi N, Barbero A, Laurent F, Schaefer DJ, Martin I, Scherberich A.

Stem Cells Transl Med. 2016 Jun 22. pii: sctm.2015-0256. [Epub ahead of print]

PMID:
27334490
19.

Cord blood chimerism and relapse after haplo-cord transplantation.

van Besien K, Koshy N, Gergis U, Mayer S, Cushing M, Rennert H, Reich-Slotky R, Mark T, Pearse R, Rossi A, Phillips A, Vasovic L, Ferrante R, Hsu YM, Shore T.

Leuk Lymphoma. 2016 Jun 23:1-10. [Epub ahead of print]

PMID:
27333804
20.

Mast Cell-Targeted Strategies in Cancer Therapy.

Ammendola M, Sacco R, Sammarco G, Luposella M, Patruno R, Gadaleta CD, Sarro GD, Ranieri G.

Transfus Med Hemother. 2016 Mar;43(2):109-13. doi: 10.1159/000444942. Epub 2016 Mar 9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk